Christopher Gagliardi
Principal, Sanofi Ventures
Boston, Massachusetts, United States
41 investmentsChristopher Gagliardi is a Principal, Sanofi Ventures based in Boston, Massachusetts, United States. Christopher Gagliardi has backed 41 companies, including Proteostasis Therapeutics, Science 37 and ImmuneXcite. Investment focus areas include Health Care, Wellness and Women Founded.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (41)
| Industry | Stage | Website | |||
|---|---|---|---|---|---|
| 1 | Proteostasis Therapeutics | — | — | — | — |
| 2 | Science 37 | — | — | — | — |
| 3 | ImmuneXcite | — | — | — | — |
| 4 | Aetion | — | — | — | — |
| 5 | NeuroVia | — | — | — | — |
| 6 | Medisafe | — | — | — | — |
| 7 | Lysosomal Therapeutics | — | — | — | — |
| 8 | Sirtris Pharmaceuticals | — | — | — | — |
| 9 | UNUM Therapeutics | — | — | — | — |
| 10 | Immune Design | — | — | — | — |
| 11 | Common Sensing | — | — | — | — |
| 12 | GlycoMimetics | — | — | — | — |
Showing 1–12 of 41
Page 1 of 4
Access Full Contact Information
Get Christopher Gagliardi's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
No credit card required
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.